North America Hernia Mesh Devices Market Size, Share & Industry Trends Analysis Report By Type (Synthetic and Biologic), By Hernia Type (Inguinal Hernia, Incisional Hernia, Femoral Hernia, and Others), By Country and Growth Forecast, 2023 - 2030

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Hernia Mesh Devices Market, by Type
1.4.2 North America Hernia Mesh Devices Market, by Hernia Type
1.4.3 North America Hernia Mesh Devices Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter Five Forces Analysis

Chapter 4. North America Hernia Mesh Devices Market by Type
4.1 North America Synthetic Market by Country
4.2 North America Biologic Market by Country

Chapter 5. North America Hernia Mesh Devices Market by Hernia Type
5.1 North America Inguinal Hernia Market by Country
5.2 North America Incisional Hernia Market by Country
5.3 North America Femoral Hernia Market by Country
5.4 North America Others Market by Country

Chapter 6. North America Hernia Mesh Devices Market by Country
6.1 US Hernia Mesh Devices Market
6.1.1 US Hernia Mesh Devices Market by Type
6.1.2 US Hernia Mesh Devices Market by Hernia Type
6.2 Canada Hernia Mesh Devices Market
6.2.1 Canada Hernia Mesh Devices Market by Type
6.2.2 Canada Hernia Mesh Devices Market by Hernia Type
6.3 Mexico Hernia Mesh Devices Market
6.3.1 Mexico Hernia Mesh Devices Market by Type
6.3.2 Mexico Hernia Mesh Devices Market by Hernia Type
6.4 Rest of North America Hernia Mesh Devices Market
6.4.1 Rest of North America Hernia Mesh Devices Market by Type
6.4.2 Rest of North America Hernia Mesh Devices Market by Hernia Type

Chapter 7. Company Profiles
7.1 Becton, Dickinson, and Company
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Acquisition and Mergers:
7.1.6 SWOT Analysis
7.2 Johnson & Johnson
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental & Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 Recent strategies and developments:
7.2.5.1 Acquisition and Mergers:
7.2.6 SWOT Analysis
7.3 W. L. Gore & Associates, Inc.
7.3.1 Company Overview
7.3.2 Recent strategies and developments:
7.3.2.1 Product Launches and Product Expansions:
7.3.3 SWOT Analysis
7.4 Getinge AB (Atrium Medical Corporation)
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 SWOT Analysis
7.5 B. Braun Melsungen AG
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expenses
7.5.5 SWOT Analysis
7.6 Baxter International, Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental Analysis
7.6.4 Research & Development Expense
7.6.5 SWOT Analysis
7.7 Cook Medical, Inc. (Cook Group)
7.7.1 Company Overview
7.7.2 SWOT Analysis
7.8 Medtronic PLC
7.8.1 Company overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expenses
7.8.5 SWOT Analysis
7.9 Integra LifeSciences Holdings Corporation
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expenses
7.9.5 SWOT Analysis
7.10. Herniamesh S.r.l.
7.10.1 Company Overview
7.10.2 SWOT Analysis